{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T16:24:14Z","timestamp":1787675054711,"version":"build-2784847793"},"reference-count":172,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell Dev. Biol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Prostate cancer (PC), which is a disease driven by the activity of the androgen receptor (AR), is the most commonly diagnosed malignancy and despite advances in diagnostic and treatment strategies, PC is the second most common cause of cancer mortality in men. Taxane-based chemotherapy is the only chemotherapy that prolongs survival in metastatic PC patients. At the cellular level, taxanes bind to and stabilize microtubules (MTs), inhibiting all MT-dependent intracellular pathways. MTs are highly dynamic polymers that stochastically switch between phases of growth, shrinkage, and pause. Altered MT dynamics endow cancer cells with both survival and migratory advantages. Taxanes inhibit MT dynamics and alter the spatial organization of the MT network, thereby inhibiting intracellular trafficking of molecular cargo critical for tumor survival. In PC specifically, taxanes inhibit transcriptional activity downstream of MT stabilization and AR nuclear accumulation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Different tubulin inhibitors, even from within the same structural class as the taxanes, affect distinct parameters of MT dynamics, yet the selection of taxane for chemotherapy is not based on the particular patterns of dynamic behavior of the MT cytoskeleton in individual patients. We envisage that systematic characterization using quantitative analysis of MT dynamics in PC patient cells expressing clinically relevant protein isoforms, before and after treatment with each of the taxanes, will allow us to identify criteria for the selection of the most suitable drug combination at the onset of treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We link MT dynamics in the presence of AR variants and sensitivity\/resistance to taxanes and connect fundamental research with clinically relevant concepts to elucidate cellular mechanisms of clinical response to taxanes and, thus, advance the customization of therapy. Our computational live-cell analysis addresses questions in the context of the inherent differences in MT homeostasis as a function of AR content in PC cells, the specific parameters of MT dynamics each of the taxanes affects, and how this information can be used to match endogenous patterns of MT dynamics with drug-modulated MT behavior.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>We investigate whether the sensitivity to taxanes, evaluated by computational analysis of MTs, can be linked to gene expression of the AR and its variants, whether the resistance to taxanes can be linked to the presence of a specific AR splice variant, and whether we can identify which of the taxanes will be most effective based on the endogenous patterns of MT dynamics.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcell.2025.1723251","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T16:03:41Z","timestamp":1787673821000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Computational analysis of treatment resistant cancer cells"],"prefix":"10.3389","volume":"13","author":[{"given":"Alexandre","family":"Matov","sequence":"first","affiliation":[{"name":"DataSet Analysis LLC","place":["San Francisco, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/nrm2369","article-title":"Tracking the ends: a dynamic protein network controls the fate of microtubule tips","volume":"9","author":"Akhmanova","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"e1902971","DOI":"10.1002\/smll.201902971","article-title":"Deconstructed microfluidic bone marrow On-A-Chip to study normal and malignant hemopoietic cell-niche interactions","volume":"15","author":"Aleman","year":"2019","journal-title":"Small"},{"key":"B3","doi-asserted-by":"publisher","first-page":"3181","DOI":"10.1200\/JCO.2017.72.4138","article-title":"Randomized, noncomparative, phase II trial of early switch from docetaxel to cabazitaxel or vice versa, with integrated biomarker analysis, in men with chemotherapy-na\u00efve, metastatic, castration-resistant prostate cancer","volume":"35","author":"Antonarakis","year":"2017","journal-title":"J. Clinical Oncology Official Journal Am. Soc. Clin. Oncol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"4591","DOI":"10.1200\/JCO.2005.05.160","article-title":"Phase I trial of 177lutetium-labeled J591, a monoclonal antibody to prostate-specific membrane antigen, in patients with androgen-independent prostate cancer","volume":"23","author":"Bander","year":"2005","journal-title":"J. Clinical Oncology Official Journal Am. Soc. Clin. Oncol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.molmed.2004.07.008","article-title":"The von Hippel\u2013Lindau tumour suppressor: a multi-faceted inhibitor of tumourigenesis","volume":"10","author":"Barry","year":"2004","journal-title":"Trends Mol. Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/nrclinonc.2015.125","article-title":"Pancreatic cancer: targeting KRAS and the vitamin D receptor via microtubules","volume":"12","author":"Basseville","year":"2015","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41419-023-06012-7","article-title":"A transient increase of HIF-1\u03b1 during the G1 phase (G1-HIF) ensures cell survival under nutritional stress","volume":"14","author":"Belapurkar","year":"2023","journal-title":"Cell Death and Disease"},{"key":"B8","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/s0092-8674(00)81037-5","article-title":"Identification of a protein that interacts with tubulin dimers and increases the catastrophe rate of microtubules","volume":"84","author":"Belmont","year":"1996","journal-title":"Cell"},{"key":"B9","doi-asserted-by":"publisher","first-page":"3233","DOI":"10.1038\/s41467-020-17022-w","article-title":"A potent KRAS macromolecule degrader specifically targeting tumours with mutant KRAS","volume":"11","author":"Bery","year":"2020","journal-title":"Nat. Commun."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1056\/NEJMoa1807801","article-title":"Radical prostatectomy or watchful waiting in prostate cancer - 29-year Follow-up","volume":"379","author":"Bill-Axelson","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.ccell.2017.09.003","article-title":"Androgen receptor pathway-independent prostate cancer is sustained through FGF signaling","volume":"32","author":"Bluemn","year":"2017","journal-title":"Cancer Cell"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1021\/acscentsci.0c00411","article-title":"Targeted degradation of oncogenic KRAS(G12C) by VHL-recruiting PROTACs","volume":"6","author":"Bond","year":"2020","journal-title":"ACS Central Science"},{"key":"B13","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA A Cancer Journal Clinicians"},{"key":"B14","doi-asserted-by":"publisher","first-page":"3897","DOI":"10.3390\/cancers13153897","article-title":"The Most common VHL point mutation R167Q in hereditary VHL disease interferes with cell plasticity regulation","volume":"13","author":"Buart","year":"2021","journal-title":"Cancers"},{"key":"B15","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1242\/jcs.104.1.151","article-title":"Lytic granules from cytotoxic T cells exhibit kinesin-dependent motility on microtubules in vitro","volume":"104","author":"Burkhardt","year":"1993","journal-title":"J. Cell Sci."},{"key":"B16","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1083\/jcb.201004145","article-title":"Microtubule disruption targets HIF-\u03b1 mRNA to cytoplasmic P-bodies for translational repression","volume":"192","author":"Carbonaro","year":"2011","journal-title":"J. Cell Biol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"11859","DOI":"10.1074\/jbc.M112.345587","article-title":"Microtubules regulate Hypoxia-inducible Factor-1\u03b1 protein trafficking and activity: implications for taxane therapy","volume":"287","author":"Carbonaro","year":"2012","journal-title":"J. Biol. Chem."},{"key":"B18","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/s0955-0674(01)00289-7","article-title":"The oncoprotein 18\/stathmin family of microtubule destabilizers","volume":"14","author":"Cassimeris","year":"2002","journal-title":"Curr. Opinion Cell Biology"},{"key":"B19","doi-asserted-by":"publisher","first-page":"151075","DOI":"10.1016\/j.ejcb.2020.151075","article-title":"Microtubule-targeting agents and their impact on cancer treatment","volume":"99","author":"\u010cerm\u00e1k","year":"2020","journal-title":"Eur. Journal Cell Biology"},{"key":"B20","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41571-020-00462-0","article-title":"Broadening Horizons: the role of ferroptosis in cancer","volume":"18","author":"Chen","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"016001","DOI":"10.1088\/1478-3975\/9\/1\/016001","article-title":"Characterization of circulating tumor cell aggregates identified in patients with epithelial tumors","volume":"9","author":"Cho","year":"2012","journal-title":"Phys. Biol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1056\/NEJMoa040766","article-title":"Circulating tumor cells, disease progression, and survival in metastatic breast cancer","volume":"351","author":"Cristofanilli","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"14280","DOI":"10.1073\/pnas.1900576116","article-title":"Axonal pathology in hPSC-based models of parkinson's disease results from loss of Nrf2 transcriptional activity at the Map1b gene locus","volume":"116","author":"Czaniecki","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B24","doi-asserted-by":"publisher","first-page":"6019","DOI":"10.1158\/0008-5472.CAN-11-1417","article-title":"Taxane-induced blockade to nuclear accumulation of the androgen receptor predicts clinical responses in metastatic prostate cancer","volume":"71","author":"Darshan","year":"2011","journal-title":"Cancer Res."},{"key":"B25","doi-asserted-by":"publisher","first-page":"F1159","DOI":"10.1152\/ajprenal.00118.2005","article-title":"An incredible decade for the primary cilium: a look at a once-forgotten organelle","volume":"289","author":"Davenport","year":"2005","journal-title":"Am. Journal Physiology. Ren. Physiology"},{"key":"B26","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/nrurol.2018.22","article-title":"Cellular plasticity and the neuroendocrine phenotype in prostate cancer","volume":"15","author":"Davies","year":"2018","journal-title":"Nat. Reviews. Urol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"3291","DOI":"10.1038\/s41591-024-03204-2","article-title":"Androgen receptor pathway inhibitors and taxanes in metastatic prostate cancer: an outcome-adaptive randomized platform trial","volume":"30","author":"De Laere","year":"2024","journal-title":"Nat. Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"3039","DOI":"10.1007\/s12325-024-02918-6","article-title":"Feasibility of indirect treatment comparisons between niraparib plus abiraterone acetate and other first-line poly ADP-ribose polymerase inhibitor treatment regimens for patients with BRCA1\/2 mutation-positive metastatic castration-resistant prostate cancer","volume":"41","author":"De Santis","year":"2024","journal-title":"Adv. Therapy"},{"key":"B29","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/nprot.2016.006","article-title":"Organoid culture systems for prostate epithelial and cancer tissue","volume":"11","author":"Drost","year":"2016","journal-title":"Nat. Protoc."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.3390\/cells9051110","article-title":"Targeting GSK3 and associated signaling pathways involved in cancer","volume":"9","author":"Duda","year":"2020","journal-title":"Cells"},{"key":"B31","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1038\/ncb2994","article-title":"Increased microtubule assembly rates influence chromosomal instability in colorectal cancer cells","volume":"16","author":"Ertych","year":"2014","journal-title":"Nat. Cell Biol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"10366","DOI":"10.1073\/pnas.1900441116","article-title":"Effects of \u03b1-tubulin acetylation on microtubule structure and stability","volume":"116","author":"Eshun-Wilson","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B33","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1074\/jbc.M507378200","article-title":"Microtubule-associated protein MAP1A, MAP1B, and MAP2 proteolysis during soluble amyloid beta-peptide-induced neuronal apoptosis. Synergistic involvement of calpain and caspase-3","volume":"281","author":"Fifre","year":"2006","journal-title":"J. Biol. Chem."},{"key":"B34","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nrmicro.2017.42","article-title":"Persistent bacterial infections and persister cells","volume":"15","author":"Fisher","year":"2017","journal-title":"Nat. Reviews. Microbiol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/0264-6021:3590001","article-title":"GSK3 takes centre stage more than 20 years after its discovery","volume":"359","author":"Frame","year":"2001","journal-title":"Biochem. Journal"},{"key":"B36","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/s41391-018-0121-2","article-title":"Impact of new systemic therapies on overall survival of patients with metastatic castration-resistant prostate cancer in a hospital-based registry","volume":"22","author":"Francini","year":"2019","journal-title":"Prostate Cancer Prostatic Diseases"},{"key":"B37","doi-asserted-by":"publisher","first-page":"5548","DOI":"10.1038\/ncomms6548","article-title":"ERG induces taxane resistance in castration-resistant prostate cancer","volume":"5","author":"Galletti","year":"2014","journal-title":"Nat. Communications"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1038\/sj.bjc.6600960","article-title":"Drug resistance associated with loss of p53 involves extensive alterations in microtubule composition and dynamics","volume":"88","author":"Galmarini","year":"2003","journal-title":"Br. Journal Cancer"},{"key":"B39","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1002\/pros.22742","article-title":"Distribution of metastatic sites in patients with prostate cancer: a population-based analysis","volume":"74","author":"Gandaglia","year":"2014","journal-title":"Prostate"},{"key":"B40","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.cell.2014.08.016","article-title":"Organoid cultures derived from patients with advanced prostate cancer","volume":"159","author":"Gao","year":"2014","journal-title":"Cell"},{"key":"B41","doi-asserted-by":"publisher","first-page":"3016","DOI":"10.1016\/j.cub.2020.05.056","article-title":"Microtubule growth rates are sensitive to global and local changes in microtubule plus-end density","volume":"30","author":"Geisterfer","year":"2020","journal-title":"Curr. Biology CB"},{"key":"B42","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1006\/dbio.2001.0231","article-title":"Human cytotrophoblast expression of the von Hippel-Lindau protein is downregulated during uterine invasion in situ and upregulated by hypoxia in vitro","volume":"233","author":"Genbacev","year":"2001","journal-title":"Dev. Biology"},{"key":"B43","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.cub.2012.02.069","article-title":"EB1-recruited microtubule +TIP complexes coordinate protrusion dynamics during 3D epithelial remodeling","volume":"22","author":"Gierke","year":"2012","journal-title":"Curr. Biology CB"},{"key":"B44","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/nprot.2011.317","article-title":"Purification and direct transformation of epithelial progenitor cells from primary human prostate","volume":"6","author":"Goldstein","year":"2011","journal-title":"Nat. Protocols"},{"key":"B45","doi-asserted-by":"publisher","first-page":"11737","DOI":"10.1073\/pnas.191388598","article-title":"Resistance to Taxol in lung cancer cells associated with increased microtubule dynamics","volume":"98","author":"Gon\u00e7alves","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3389\/fceld.2024.1477346","article-title":"Not dead yet","volume":"3","author":"Green","year":"2024","journal-title":"Cell Death Survival Cancer Normal Physiology"},{"key":"B47","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1042\/BST20190033","article-title":"Nicotinamide adenine dinucleotide (NAD+): essential redox metabolite, co-substrate and an anti-cancer and anti-ageing therapeutic target","volume":"48","author":"Griffiths","year":"2020","journal-title":"Biochem. Soc. Transactions"},{"key":"B48","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1158\/0008-5472.CAN-08-3795","article-title":"A novel androgen receptor splice variant is up-regulated during prostate cancer progression and promotes androgen depletion-resistant growth","volume":"69","author":"Guo","year":"2009","journal-title":"Cancer Res."},{"key":"B49","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.3390\/cells10082092","article-title":"GSK3 as a regulator of Cytoskeleton Architecture: consequences for health and disease","volume":"10","author":"Hajka","year":"2021","journal-title":"Cells"},{"key":"B50","doi-asserted-by":"publisher","first-page":"11218","DOI":"10.1021\/acs.jmedchem.9b01393","article-title":"Discovery of highly potent and efficient PROTAC degraders of androgen Receptor (AR) by employing weak binding affinity VHL E3 Ligase ligands","volume":"62","author":"Han","year":"2019","journal-title":"J. Medicinal Chemistry"},{"key":"B51","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/nature24297","article-title":"Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition","volume":"551","author":"Hangauer","year":"2017","journal-title":"Nature"},{"key":"B52","doi-asserted-by":"publisher","first-page":"E2443","DOI":"10.1073\/pnas.1404269111","article-title":"NAD+ and SIRT3 control microtubule dynamics and reduce susceptibility to antimicrotubule agents","volume":"111","author":"Harkcom","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B53","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1093\/toxsci\/kfab009","article-title":"High-Throughput transcriptomics platform for screening environmental chemicals","volume":"181","author":"Harrill","year":"2021","journal-title":"Toxicol. Sciences An Official Journal Soc. Toxicol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.ajhg.2013.03.022","article-title":"Sherlock: detecting gene-disease associations by matching patterns of expression QTL and GWAS","volume":"92","author":"He","year":"2013","journal-title":"Am. Journal Human Genetics"},{"key":"B55","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/s41392-024-01891-4","article-title":"Drug tolerant persister cell plasticity in cancer: a revolutionary strategy for more effective anticancer therapies","volume":"9","author":"He","year":"2024","journal-title":"Signal Transduction Targeted Therapy"},{"key":"B56","doi-asserted-by":"publisher","first-page":"5784","DOI":"10.1128\/MCB.00232-06","article-title":"Priming-dependent phosphorylation and regulation of the tumor suppressor pVHL by glycogen synthase kinase 3","volume":"26","author":"Hergovich","year":"2006","journal-title":"Mol. Cell Biol."},{"key":"B57","article-title":"Bootstrap methods and permutation tests","volume-title":"Introduction to the practice of statistics","author":"Hesterberg","year":"2005"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1056\/NEJMoa1917239","article-title":"KRAS(G12C) inhibition with Sotorasib in advanced solid tumors","volume":"383","author":"Hong","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"B59","doi-asserted-by":"publisher","first-page":"e19059","DOI":"10.1371\/journal.pone.0019059","article-title":"Expression of androgen receptor splice variants in prostate cancer bone metastases is associated with castration-resistance and short survival","volume":"6","author":"H\u00f6rnberg","year":"2011","journal-title":"PLoS One"},{"key":"B60","first-page":"554","article-title":"Machine analysis of bubble chamber pictures","volume-title":"International conference on high-energy accelerators and instrumentation","author":"Hough","year":"1959"},{"key":"B61","doi-asserted-by":"publisher","first-page":"15338","DOI":"10.1073\/pnas.0902317106","article-title":"Op18 reveals the contribution of non-kinetochore microtubules to the dynamic Organization of the vertebrate meiotic spindle","volume":"106","author":"Houghtaling","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B62","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1158\/0008-5472.CAN-08-2764","article-title":"Ligand-independent androgen receptor variants derived from splicing of cryptic exons signify hormone-refractory prostate cancer","volume":"69","author":"Hu","year":"2009","journal-title":"Cancer Res."},{"key":"B63","doi-asserted-by":"publisher","first-page":"R1287","DOI":"10.1016\/j.cub.2017.10.044","article-title":"Causes and consequences of microtubule acetylation","volume":"27","author":"Janke","year":"2017","journal-title":"Curr. Biology CB"},{"key":"B64","doi-asserted-by":"publisher","first-page":"030514","DOI":"10.1117\/1.3456369","article-title":"Speckle fluctuation spectroscopy of intracellular motion in living tissue using coherence-domain digital holography","volume":"15","author":"Jeong","year":"2010","journal-title":"J. Biomedical Optics"},{"key":"B65","article-title":"Investigating microtubule growth dynamics in discrete cytoplasmic volumes","volume":"24","author":"Jevtic","year":"2013","journal-title":"Mol. Biology Cell"},{"key":"B66","article-title":"Microtubule dynamics are modulated by changes in cytoplasmic volume: a possible mechanism for mitotic spindle scaling","volume":"25","author":"Jevtic","year":"2014","journal-title":"Mol. Biology Cell"},{"key":"B67","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s13578-023-01130-3","article-title":"NADH elevation during chronic hypoxia leads to VHL-mediated HIF-1\u03b1 degradation via SIRT1 inhibition","volume":"13","author":"Joo","year":"2023","journal-title":"Cell and Bioscience"},{"key":"B68","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/nrc1317","article-title":"Microtubules as a target for anticancer drugs","volume":"4","author":"Jordan","year":"2004","journal-title":"Nat. Reviews. Cancer."},{"key":"B69","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.molcel.2008.04.009","article-title":"Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway","volume":"30","author":"Kaelin","year":"2008","journal-title":"Mol. Cell"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1080\/14737140.2018.1527688","article-title":"A comprehensive review of protein kinase inhibitors for cancer therapy","volume":"18","author":"Kannaiyan","year":"2018","journal-title":"Expert Review Anticancer Therapy."},{"key":"B71","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/nrc2803","article-title":"Microtubules and resistance to tubulin-binding agents","volume":"10","author":"Kavallaris","year":"2010","journal-title":"Nat. Reviews. Cancer."},{"key":"B72","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1002\/pros.22665","article-title":"Metabolic reprogramming and validation of hyperpolarized 13C lactate as a prostate cancer biomarker using a human prostate tissue slice culture bioreactor","volume":"73","author":"Keshari","year":"2013","journal-title":"Prostate"},{"key":"B73","doi-asserted-by":"publisher","first-page":"4909","DOI":"10.1038\/s41388-020-1336-y","article-title":"PROteolysis TArgeting Chimeras (PROTACs) as emerging anticancer therapeutics","volume":"39","author":"Khan","year":"2020","journal-title":"Oncogene"},{"key":"B74","first-page":"83","article-title":"Sulla determinazione emp\u00edrica di uma legge di distribuzione","volume":"4","author":"Kolmogorov","year":"1933","journal-title":"G. dell\u2019Istituto Ital. Degli Attuari"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1002\/9780470151808.sc05a06s27","article-title":"Retroviral gene expression control in primary organoid cultures","volume":"27","author":"Koo","year":"2013","journal-title":"Curr. Protocols Stem Cell Biology"},{"key":"B76","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1002\/nav.3800020109","article-title":"The Hungarian method for the assignment problem","volume":"2","author":"Kuhn","year":"1955","journal-title":"Nav. Res. Logist. Q."},{"key":"B77","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1083\/jcb.200901042","article-title":"GSK3\u03b2 phosphorylation modulates CLASP\u2013microtubule association and lamella microtubule attachment","volume":"184","author":"Kumar","year":"2009","journal-title":"J. Cell Biol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"120059","DOI":"10.1016\/j.bbamcr.2025.120059","article-title":"SYK overexpression enhances microtubule instability in an MDA-MB-231-derived paclitaxel-resistant cell line","volume":"1872","author":"Kuo","year":"2025","journal-title":"Biochimica Biophysica Acta (BBA) - Mol. Cell Res."},{"key":"B79","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1093\/neuonc\/nox215","article-title":"A molecular cascade modulates MAP1B and confers resistance to mTOR inhibition in human glioblastoma","volume":"20","author":"Laks","year":"2018","journal-title":"Neuro-oncology"},{"key":"B80","first-page":"353","article-title":"Memoire sur les approximations des formules qui sont fonctions de tres grands nombres et sur leur application aux probabilites","author":"Laplace","year":"1810","journal-title":"M\u00e9moires l'Acad\u00e9mie R. Sci."},{"key":"B81","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/s0092-8674(00)81280-5","article-title":"Cell migration: a physically integrated molecular process","volume":"84","author":"Lauffenburger","year":"1996","journal-title":"Cell"},{"key":"B82","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.urolonc.2015.05.006","article-title":"Glycogen synthase kinase-3: a potential preventive target for prostate cancer management","volume":"33","author":"Li","year":"2015","journal-title":"Urol. Oncology"},{"key":"B83","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s10851-014-0541-0","article-title":"Image matching using generalized scale-space interest points","volume":"52","author":"Lindeberg","year":"2014","journal-title":"J. Math. Imaging Vis."},{"key":"B84","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.molcel.2006.10.009","article-title":"A chaperone-dependent GSK3\u03b2 transitional intermediate mediates activation-loop autophosphorylation","volume":"24","author":"Lochhead","year":"2006","journal-title":"Mol. Cell"},{"key":"B85","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1101\/sqb.2008.73.012","article-title":"Epithelial stem cells of the prostate and their role in cancer progression","volume":"73","author":"Lukacs","year":"2008","journal-title":"Cold Spring Harb. Symposia Quantitative Biology"},{"key":"B86","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.cell.2009.01.010","article-title":"SnapShot: Microtubule regulators I","volume":"136","author":"Lyle","year":"","journal-title":"Cell"},{"key":"B87","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.cell.2009.01.011","article-title":"SnapShot: Microtubule regulators II","volume":"136","author":"Lyle","year":"","journal-title":"Cell"},{"key":"B88","doi-asserted-by":"publisher","first-page":"391","DOI":"10.3389\/fnmol.2017.00391","article-title":"Differential roles of glycogen synthase kinase 3 subtypes alpha and beta in cortical development","volume":"10","author":"Ma","year":"2017","journal-title":"Front. Molecular Neuroscience"},{"key":"B89","first-page":"1","article-title":"On the generalised distance in statistics","volume":"80","author":"Mahalanobis","year":"1936","journal-title":"J. Asiatic Soc. Bengal"},{"key":"B90","first-page":"24310568","article-title":"Analysis of genome-wide cell-free DNA fragment length distributions in colorectal cancer medRxiv:2024","author":"Matov","year":""},{"key":"B91","first-page":"24311450","article-title":"Analysis of multiple myeloma drug efficacy","volume":"2024","author":"Matov","year":"","journal-title":"medRxiv"},{"key":"B92","first-page":"601275","article-title":"Measurements of contractility in actin convergence zone and KIF11-Inhibited mitotic spindles","volume":"2024","author":"Matov","year":"","journal-title":"bioRxiv"},{"key":"B93","first-page":"5072927","article-title":"Microtubule regulation in cancer cells SSRN:2024","author":"Matov","year":""},{"key":"B94","article-title":"Mitosis, cytoskeleton regulation, and drug resistance in receptor triple-negative breast cancer","author":"Matov","year":""},{"key":"B95","first-page":"5061950","article-title":"Modulation of the cytoskeleton for cancer therapy SSRN:2024","author":"Matov","year":""},{"key":"B96","first-page":"24311304","article-title":"Quantitative microscopy in medicine","volume":"2024","author":"Matov","year":"","journal-title":"medRxiv"},{"key":"B97","first-page":"4909311","article-title":"Quantitative video microscopy in medicine","volume":"2024","author":"Matov","year":"","journal-title":"SSRN"},{"key":"B98","first-page":"5112427","article-title":"Microtubule dysregulation in prostate cancer metastasis to the vertebrae SSRN:2025","author":"Matov","year":""},{"key":"B99","first-page":"5130515","article-title":"Quantitative cell division and migration in medicine","volume":"2025","author":"Matov","year":"","journal-title":"SSRN"},{"key":"B100","article-title":"Analysis of the movement of microtubule plus-end tracking protein EB1","volume":"16","author":"Matov","year":"2005","journal-title":"Mol. Biology Cell"},{"key":"B101","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/nmeth.1493","article-title":"Analysis of microtubule dynamic instability using a plus-end growth marker","volume":"7","author":"Matov","year":"2010","journal-title":"Nat. Methods"},{"key":"B102","doi-asserted-by":"publisher","first-page":"2888","DOI":"10.1158\/1538-7445.am2013-2888","article-title":"Computational analysis of microtubule dynamics for personalized cancer therapy","volume":"73","author":"Matov","year":"2013","journal-title":"Cancer Res."},{"key":"B103","article-title":"Investigating microtubule growth dynamics and spindle positioning regulation in breast cancer cells","volume":"26","author":"Matov","year":"2015","journal-title":"Mol. Biology Cell"},{"key":"B104","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1158\/1538-7445.am2016-243","article-title":"Investigating microtubule growth dynamics in patient-derived metastatic prostate cancer cells","volume":"76","author":"Matov","year":"2016","journal-title":"Cancer Res."},{"key":"B105","first-page":"410","volume-title":"Fast line detection algorithms based on combinatorial optimization","author":"Mattavelli","year":"2001"},{"key":"B106","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1038\/labinvest.2013.141","article-title":"Optimization and comprehensive characterization of a faithful tissue culture model of the benign and malignant human prostate","volume":"94","author":"Maund","year":"2014","journal-title":"Laboratory Investigation; a Journal Technical Methods Pathology"},{"key":"B107","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/978-1-4757-3401-0_24","article-title":"The pVHL-hIF-1 system. A key mediator of oxygen homeostasis","volume":"502","author":"Maxwell","year":"2001","journal-title":"Adv. Experimental Medicine Biology"},{"key":"B108","doi-asserted-by":"publisher","first-page":"3248","DOI":"10.1158\/1535-7163.MCT-06-0227","article-title":"Therapeutic interactions between stathmin inhibition and chemotherapeutic agents in prostate cancer","volume":"5","author":"Mistry","year":"2006","journal-title":"Mol. Cancer Ther."},{"key":"B109","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1091\/mbc.E10-04-0335","article-title":"The proliferation rate paradox in antimitotic chemotherapy","volume":"23","author":"Mitchison","year":"2012","journal-title":"Mol. Biol. Cell"},{"key":"B110","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s12915-021-01092-3","article-title":"So many ways to naturally kill a cancer cell","volume":"19","author":"Mitchison","year":"2021","journal-title":"BMC Biology"},{"key":"B111","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1038\/nmeth.3483","article-title":"Inferring transient particle transport dynamics in live cells","volume":"12","author":"Monnier","year":"2015","journal-title":"Nat. Methods"},{"key":"B112","doi-asserted-by":"publisher","first-page":"5913","DOI":"10.1158\/1078-0432.CCR-11-0728","article-title":"Resistance to CYP17A1 inhibition with abiraterone in castration-resistant prostate cancer: induction of steroidogenesis and androgen receptor splice variants","volume":"17","author":"Mostaghel","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"B113","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/s0076-6879(00)25449-9","article-title":"Use and properties of ROCK-specific inhibitor Y-27632","volume":"325","author":"Narumiya","year":"2000","journal-title":"Methods Enzymology"},{"key":"B114","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1002\/pros.23313","article-title":"LuCaP prostate cancer patient-derived xenografts reflect the molecular heterogeneity of advanced disease an--d serve as models for evaluating cancer therapeutics","volume":"77","author":"Nguyen","year":"2017","journal-title":"Prostate"},{"key":"B115","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/s41401-021-00632-5","article-title":"Discovery of novel antagonists targeting the DNA binding domain of androgen receptor by integrated docking-based virtual screening and bioassays","volume":"43","author":"Pang","year":"2022","journal-title":"Acta Pharmacologica Sin."},{"key":"B116","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"B117","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1056\/NEJMoa041318","article-title":"Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer","volume":"351","author":"Petrylak","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"B118","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1093\/bioinformatics\/bty878","article-title":"BMDExpress 2: enhanced transcriptomic dose-response analysis workflow","volume":"35","author":"Phillips","year":"2018","journal-title":"Bioinformatics"},{"key":"B119","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1091\/mbc.e02-09-0607","article-title":"Organization and dynamics of growing microtubule plus ends during early mitosis","volume":"14","author":"Piehl","year":"2003","journal-title":"Mol. Biology Cell"},{"key":"B120","doi-asserted-by":"publisher","first-page":"692574","DOI":"10.3389\/fphar.2021.692574","article-title":"PROTAC: an effective targeted protein degradation strategy for cancer therapy","volume":"12","author":"Qi","year":"2021","journal-title":"Front. Pharmacology"},{"key":"B121","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1016\/s0031-3203(00)00136-9","article-title":"Unimodal thresholding","volume":"34","author":"Rosin","year":"2001","journal-title":"Pattern Recognit."},{"key":"B122","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1038\/s41568-024-00737-z","article-title":"Cancer drug-tolerant persister cells: from biological questions to clinical opportunities","volume":"24","author":"Russo","year":"2024","journal-title":"Nat. Reviews. Cancer."},{"key":"B123","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.gde.2013.11.012","article-title":"Organoid cultures for the analysis of cancer phenotypes","volume":"24","author":"Sachs","year":"2014","journal-title":"Curr. Opin. Genet. Dev."},{"key":"B124","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1038\/s41591-023-02284-w","article-title":"Neoadjuvant enoblituzumab in localized prostate cancer: a single-arm, phase 2 trial","volume":"29","author":"Shenderov","year":"2023","journal-title":"Nat. Medicine"},{"key":"B125","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/j.molcel.2007.07.023","article-title":"Structural basis of microtubule plus end tracking by XMAP215, CLIP-170, and EB1","volume":"27","author":"Slep","year":"2007","journal-title":"Mol. Cell"},{"key":"B126","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/nature01874","article-title":"Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumour suppressor pVHL","volume":"425","author":"Staller","year":"2003","journal-title":"Nature"},{"key":"B127","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.ccr.2014.02.017","article-title":"Dragging ras back in the ring","volume":"25","author":"Stephen","year":"2014","journal-title":"Cancer Cell"},{"key":"B128","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1093\/jnci\/djad184","article-title":"Molecular features of prostate cancer after neoadjuvant therapy in the phase 3 CALGB 90203 trial","volume":"116","author":"Sumiyoshi","year":"2024","journal-title":"J. Natl. Cancer Inst."},{"key":"B129","doi-asserted-by":"publisher","first-page":"2715","DOI":"10.1172\/JCI41824","article-title":"Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variant","volume":"120","author":"Sun","year":"2010","journal-title":"J. Clin. Invest"},{"key":"B130","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1038\/onc.2013.85","article-title":"BRCA1 regulates microtubule dynamics and taxane-induced apoptotic cell signaling","volume":"33","author":"Sung","year":"2014","journal-title":"Oncogene"},{"key":"B131","article-title":"Molecular determinants of taxane activity using circulating tumor cells (CTCs) from castrate-resistant prostate cancer patients","volume-title":"Understanding cancer: genomes to devices symposium, New York Academy of medicine","author":"Sung","year":"2012"},{"key":"B132","doi-asserted-by":"publisher","first-page":"3492","DOI":"10.1158\/1538-7445.am2013-3492","article-title":"Using CTCs to interrogate mechanisms of taxane resistance in the prospective TAXYNERGY clinical trial in prostate cancer","volume":"73","author":"Sung","year":"2013","journal-title":"Cancer Res."},{"key":"B133","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1056\/NEJMoa1503747","article-title":"Chemohormonal therapy in metastatic hormone-sensitive prostate cancer","volume":"373","author":"Sweeney","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"B134","article-title":"First order error propagation in a stagewise smoothing procedure for satellite obvervations","volume":"6","author":"Swerling","year":"1959","journal-title":"J. Astronautical Sci."},{"key":"B135","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1056\/NEJMoa040720","article-title":"Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer","volume":"351","author":"Tannock","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"B136","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1158\/1538-7445.am2014-923","article-title":"Analysis of microtubule perturbations and androgen receptor localization in circulating tumor cells from castration resistant prostate cancer patients as predictive biomarkers of clinical response to docetaxel chemotherapy","volume":"74","author":"Tasaki","year":"2014","journal-title":"Cancer Res."},{"key":"B137","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1158\/0008-5472.CAN-12-0783","article-title":"Androgen receptor on the move: boarding the microtubule expressway to the nucleus","volume":"72","author":"Thadani-Mulero","year":"2012","journal-title":"Cancer Res."},{"key":"B138","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.1158\/0008-5472.CAN-13-2876","article-title":"Androgen receptor splice variants determine taxane sensitivity in prostate cancer","volume":"74","author":"Thadani-Mulero","year":"2014","journal-title":"Cancer Res."},{"key":"B139","doi-asserted-by":"publisher","first-page":"3264","DOI":"10.1016\/j.devcel.2021.09.023","article-title":"CLIP-170S is a microtubule +TIP variant that confers resistance to taxanes by impairing drug-target engagement","volume":"56","author":"Thakkar","year":"2021","journal-title":"Dev. Cell"},{"key":"B140","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/ncb1579","article-title":"pVHL and GSK3[beta] are components of a primary cilium-maintenance signalling network","volume":"9","author":"Thoma","year":"","journal-title":"Nat. Cell Biol."},{"key":"B141","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.4161\/cc.6.15.4518","article-title":"The VHL tumor suppressor: riding tandem with GSK3beta in primary cilium maintenance","volume":"6","author":"Thoma","year":"","journal-title":"Cell CycleGeorget. Tex."},{"key":"B142","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1083\/jcb.201006059","article-title":"Quantitative image analysis identifies pVHL as a key regulator of microtubule dynamic instability","volume":"190","author":"Thoma","year":"2010","journal-title":"J. Cell Biol."},{"key":"B143","doi-asserted-by":"publisher","first-page":"e1003166","DOI":"10.1371\/journal.pcbi.1003166","article-title":"Parameter trajectory analysis to identify treatment effects of pharmacological interventions","volume":"9","author":"Tiemann","year":"2013","journal-title":"PLoS Comput. Biol."},{"key":"B144","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1126\/science.1117679","article-title":"Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer","volume":"310","author":"Tomlins","year":"2005","journal-title":"Sci. New York, N.Y"},{"key":"B145","doi-asserted-by":"publisher","first-page":"e010833","DOI":"10.1136\/jitc-2024-010833","article-title":"Neoadjuvant anti-PD-1-based immunotherapy: evolving a new standard of care","volume":"13","author":"Topalian","year":"2025","journal-title":"J. Immunotherapy Cancer"},{"key":"B146","article-title":"Microtubules regulate tumor microenvironment remodeling","volume-title":"Understanding cancer: genomes to devices symposium, New York Academy of medicine","author":"Tran","year":"2012"},{"key":"B147","doi-asserted-by":"publisher","first-page":"5162","DOI":"10.1158\/1538-7445.am2013-5162","article-title":"Microtubule stabilization alters tumor secretome and fibroblast activation","volume":"73","author":"Tran","year":"2013","journal-title":"Cancer Res."},{"key":"B148","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1146\/annurev-med-081522-031439","article-title":"Prostate-Specific membrane antigen: gateway to management of advanced prostate cancer","volume":"75","author":"Unterrainer","year":"2024","journal-title":"Annu. Review Medicine"},{"key":"B149","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/S1470-2045(15)00489-1","article-title":"Addition of docetaxel or bisphosphonates to standard of care in men with localised or metastatic, hormone-sensitive prostate cancer: a systematic review and meta-analyses of aggregate data","volume":"17","author":"Vale","year":"2016","journal-title":"Lancet. Oncol."},{"key":"B150","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1016\/S0006-3495(03)74564-0","article-title":"Recovery, visualization, and analysis of actin and tubulin polymer flow in live cells: a Fluorescence Speckle Microscopy Study","volume":"85","author":"Vallotton","year":"2003","journal-title":"Biophys. J."},{"key":"B151","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.cell.2015.03.053","article-title":"Prospective derivation of a living organoid biobank of colorectal cancer patients","volume":"161","author":"van de Wetering","year":"2015","journal-title":"Cell"},{"key":"B152","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1002\/pros.24104","article-title":"Imaging expression of prostate-specific membrane antigen and response to PSMA-targeted \u03b2-emitting radionuclide therapies in metastatic castration-resistant prostate cancer","volume":"81","author":"Vlachostergios","year":"2021","journal-title":"Prostate"},{"key":"B153","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/s41420-021-00726-3","article-title":"GSK-3\u03b2 manipulates ferroptosis sensitivity by dominating iron homeostasis","volume":"7","author":"Wang","year":"2021","journal-title":"Cell Death Discovery"},{"key":"B154","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/s12964-023-01170-9","article-title":"The emerging roles of MAPK-AMPK in ferroptosis regulatory network","volume":"21","author":"Wang","year":"2023","journal-title":"Cell Communication Signaling CCS"},{"key":"B155","doi-asserted-by":"publisher","first-page":"16759","DOI":"10.1073\/pnas.1012443107","article-title":"Inaugural article: constitutively active androgen receptor splice variants expressed in castration-resistant prostate cancer require full-length androgen receptor","volume":"107","author":"Watson","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B156","doi-asserted-by":"publisher","first-page":"834","DOI":"10.2174\/156800910793358005","article-title":"RAS pathways in prostate cancer - mediators of hormone resistance?","volume":"10","author":"Whitaker","year":"2010","journal-title":"Curr. Cancer Drug Targets"},{"key":"B157","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/0042-6989(77)90152-3","article-title":"Threshold visibility of frequency gradient patterns","volume":"17","author":"Wilson","year":"1977","journal-title":"Vis. Res."},{"key":"B158","first-page":"60","article-title":"Glycogen Synthase Kinase 3 (GSK3) inhibitor - Pipeline Insight, 2022","author":"Wood","year":"2022","journal-title":"Clin. Trials"},{"key":"B159","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1016\/j.cell.2018.04.034","article-title":"Inactivation of CDK12 delineates a distinct immunogenic class of advanced prostate cancer","volume":"173","author":"Wu","year":"2018","journal-title":"Cell"},{"key":"B160","first-page":"138","article-title":"Reliable tracking of large scale dense antiparallel particle motion for fluorescence live cell imaging","volume-title":"Proc. IEEE computer vision and pattern recognition","author":"Yang","year":"2005"},{"key":"B161","doi-asserted-by":"publisher","first-page":"112945","DOI":"10.1016\/j.celrep.2023.112945","article-title":"HIF-1\u03b1 drives resistance to ferroptosis in solid tumors by promoting lactate production and activating SLC1A1","volume":"42","author":"Yang","year":"2023","journal-title":"Cell Reports"},{"key":"B162","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1083\/jcb.201010021","article-title":"Circulating tumor cells: approaches to isolation and characterization","volume":"192","author":"Yu","year":"2011","journal-title":"J. Cell Biol."},{"key":"B163","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1080\/14737140.2024.2379913","article-title":"PROTACing the androgen receptor and other emerging therapeutics in prostate cancer","volume":"24","author":"Zang","year":"2024","journal-title":"Expert Rev. Anticancer Ther."},{"key":"B164","doi-asserted-by":"publisher","first-page":"229ra243","DOI":"10.1126\/scitranslmed.3007965","article-title":"Cytotoxicity of paclitaxel in breast cancer is due to chromosome missegregation on multipolar spindles","volume":"6","author":"Zasadil","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"B165","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1089\/ten.TEC.2013.0490","article-title":"Patient-specific 3D microfluidic tissue model for multiple myeloma","volume":"20","author":"Zhang","year":"2014","journal-title":"Tissue Eng. Part C Methods"},{"key":"B166","doi-asserted-by":"publisher","first-page":"e0125995","DOI":"10.1371\/journal.pone.0125995","article-title":"Ex Vivo maintenance of primary human multiple myeloma cells through the optimization of the osteoblastic niche","volume":"10","author":"Zhang","year":"2015","journal-title":"PloS One"},{"key":"B167","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1021\/acs.biochem.7b01113","article-title":"Design of small molecules that compete with nucleotide binding to an engineered oncogenic KRAS allele","volume":"57","author":"Zhang","year":"2018","journal-title":"Biochemistry"},{"key":"B168","doi-asserted-by":"publisher","first-page":"eadn8709","DOI":"10.1126\/sciadv.adn8709","article-title":"Androgen deprivation therapy exacerbates alzheimer's-associated cognitive decline via increased brain immune cell infiltration","volume":"10","author":"Zhang","year":"2024","journal-title":"Sci. Advances"},{"key":"B169","doi-asserted-by":"publisher","first-page":"9281","DOI":"10.1021\/acs.jmedchem.9b01264","article-title":"Discovery of SIAIS178 as an Effective BCR-ABL Degrader by Recruiting Von Hippel-Lindau (VHL) E3 Ubiquitin Ligase","volume":"62","author":"Zhao","year":"2019","journal-title":"J. Medicinal Chemistry"},{"key":"B170","doi-asserted-by":"publisher","first-page":"7992","DOI":"10.1158\/0008-5472.CAN-10-0585","article-title":"Tubulin-targeting chemotherapy impairs androgen receptor activity in prostate cancer","volume":"70","author":"Zhu","year":"2010","journal-title":"Cancer Res."},{"key":"B171","doi-asserted-by":"publisher","first-page":"6390","DOI":"10.1038\/s41467-022-34077-z","article-title":"Small molecules targeting the disordered transactivation domain of the androgen receptor induce the formation of collapsed helical states","volume":"13","author":"Zhu","year":"2022","journal-title":"Nat. Communications"},{"key":"B172","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/s41391-024-00797-0","article-title":"Natural killer cell infiltration in prostate cancers predict improved patient outcomes","volume":"28","author":"Zorko","year":"2024","journal-title":"Prostate Cancer Prostatic Diseases"}],"container-title":["Frontiers in Cell and Developmental Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2025.1723251\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T16:03:46Z","timestamp":1787673826000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2025.1723251\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,25]]},"references-count":172,"alternative-id":["10.3389\/fcell.2025.1723251"],"URL":"https:\/\/doi.org\/10.3389\/fcell.2025.1723251","relation":{},"ISSN":["2296-634X"],"issn-type":[{"value":"2296-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,25]]},"article-number":"1723251"}}